Center MM, Jemal A, Lortet-Tieulent J, Ward E, Ferlay J, Brawley O, Bray F (2012) International variation in prostate cancer incidence and mortality rate. Eur Urol 61:1079–1092
Article
Google Scholar
Matthew RC, Joseph CP, Katsuto S, Peter RC (2013) Neoplasm of the prostate gland. Smith and Tanagho’s General urology. 18th edn, McGraw Hill, pp 350–379
Osegbe DN (1997) Prostate cancer in Nigeria: facts and nonfacts. J Urol 157(4):1340–1343
Article
CAS
Google Scholar
Taneja S, Bjurlin M, Ballentine H, Carter H, Cookson M, Gomella L, Penson D, Schellhammer P, Schlossberg S, Troyer D, Wheeler T, Stinchcomb S (2013) AUA/optimal techniques of prostate biopsy and specimen handling PROSTATE
Ojewola RW, Tijani KH, Jeje EA, Anunobi CC, Ogunjimi MA, Ezenwa EV, Ogundiniyi OS (2012) Detection of prostate cancer: comparison of cancer detection rates of sextant and extended ten-core biopsy protocols. Nigerian Postgrad Med J 19(3):137–142
CAS
Google Scholar
Joshi R (2020) Transrectal ultrasound guided prostatic biopsy and its complications: a descriptive cross-sectional study. JNMA J Nepal Med Assoc 58(221):44–47
PubMed
PubMed Central
Google Scholar
Shittu OB, Kamara TB (2001) Transrectal biopsy of the prostate gland in Ibadan. Niger J Surg Res 3:3–4
Article
Google Scholar
Ojewola RW, Tijani KH, Jeje EA, Ogunjimi MA, Anunobi CC, Adesanya AO (2013) An evaluation of the usefulness of prostate specific antigen and digital rectal examination in the diagnosis of prostate cancer in an unscreened population: an experience in a nigerian teaching hospital. WAJM 32(1):8–13
CAS
Google Scholar
Mbaeri TU, Abiahu JA, Orakwe JC, Oranusi CK, Nwofor AME, Obiesie EA, Nwadi UV, Okoli CC (2017) Complications of prostate cancer in two centers in Anambra state. Orient J Med 29:3–4
Google Scholar
Agbugui JO, Obarisiagbon EO, Osaigbovo EO, Osime CO, Akumabor PN (2014) Antibiotic prophylaxis for transrectal prostate biopsy: a comparison of one day and five day regimen. Niger Postgrad Med J 21(3):213–217
PubMed
CAS
Google Scholar
Puig J, Darnell A, Bermudez P, Malet A, Serrate G, Bare M, Prats J (2006) Transrectal ultrasound-guided prostate biopsy: is antibiotic prophylaxis necessary? Eur Radiol 16:939–943
Article
Google Scholar
Zani EL, Clark OA, Rodrigues NN (2011) Antibiotic prophylaxis for transrectal prostate biopsy. Cochrane Database Syst Rev 11(5):CD006576
Google Scholar
Aron M, Rajeev TP, Gupta NP (2000) Antibiotic prophylaxis for transrectal needle biopsy of the prostate: a randomized controlled study. BJU Int 85:682–685
Article
CAS
Google Scholar
Fisher LD (1998) Self-designing clinical trials. Stat Med 17:1151–1562
Article
Google Scholar
Stephen OI, Olufunmilade AO, Muftau JB, Michael OA, Victor PNM, Julius OE (2013) Prevalence and characteristics of prostate cancer among participants of a community-based screening in Nigeria using serum prostate specific antigen and digital rectal examination. Pan African Med J 15:129–136
Google Scholar
Williamson DA, Barrett LK, Rogers BA, Freeman JT, Hadway P, Paterson DL (2013) Infectious complication following transrectal ultrasound-guided prostate biopsy: new challenges in the era of multi-drug resistant Escherichia coli. Clin Infect Dis 57(2):267–274
Article
Google Scholar
Weinstein MP, Limbago B, Patel J, Mathers A, Campeau S, Mazzulli T et al. (2018) M100 performance standards for antimicrobial susceptibility testing. In: CLSI
Cheesebrough Monica-Examination of urine (2006). In: Monica C (ed) District Laboratory Practice in tropical countries. Part 2. Cambridge University Press, Cambridge, pp 105–114
Google Scholar
Marino K, Parlee A, Orlando R, Lerner L, Strymish J, Gupta K (2015) Comparative effectiveness of single versus combination antibiotic prophylaxis for infections after transrectal prostate biopsy. Antimicrob Agents Chemother 59(12):7273–7275
Article
CAS
Google Scholar
Williamson DA, Roberts SA, Paterson DL, Sidjabat H, Silvey A, Masters J et al (2012) Escherichia coli bloodstream infection after transrectal ultrasound-guided prostate biopsy: implication of fluoroquinolone-resistant sequence type 131 as a major causative pathogen. Clin Infect Dis 54:1406–1412
Article
CAS
Google Scholar
Rodriguez-Bano J, Picon E, Gijon P, Harnendez JR, Ruiz M, Carmen P et al (2010) community-onset bacteremia due to extended-spectrum beta-lactamase-producing E. coli: risk factors and prognosis. Clin Infect Dis 50:40–48
Article
CAS
Google Scholar
Tumbarello M, Trecarichi EM, Bassetti M, De Guiseppe RF, Spanu T, Di Meco E et al (2011) Identifying patients harbouring extended-spectrum beta-lactamase-producing Enterobacteriaceae on hospital admission: derivation and validation of scoring system. Antimicrob Agents Chemothera 55:3485–3490
Article
CAS
Google Scholar
Lee C, You D, Jeong IG, Hong JH, Choo MS, Ahn H et al (2015) Antibiotic prophylaxis with intravenous ceftriaxone and fluoroquinolone reduces infectious complications after transrectal ultrasound-guided prostate biopsy. Korean J Urol 56(6):466–472
Article
Google Scholar
Ugwumba FO II, Nnabugwu KNE, Okoh AD, Udeh EI (2017) Rates and determinants of complications following Trans-Rectal Prostate Biopsy in Enugu. Nigeria JAMMR 23(10):1–8
Article
Google Scholar
Magiorakos AP, Srinivasan A, Carey R, Carmeli Y, Falagas M, Giske C et al (2012) Multidrug-resistant, extensively drug-resistant and pan drug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18(3):268–281
Article
CAS
Google Scholar
Karlowsky JA, Kelly LJ, Thornsberry C, Jones ME, Evangelista AT, Critchley IA, Sahm DF (2002) Susceptibility to fluoroquinolones among commonly isolated Gram-negative bacilli in 2000: TRUST and TSN data for the United States. Tracking resistance in the United States today. The surveillance network. Int J Antimicrob Agents 19:21–31
Article
CAS
Google Scholar